Alder BioPharmaceuticals® to Webcast Upcoming Breakfast Symposium with Key Opinion Leaders
BOTHELL, Wash., June 19, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today announced that it will webcast its upcoming …